Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on October 29, 2009

Arteriosclerosis, Thrombosis, and Vascular Biology. 2009
Published online before print October 29, 2009, doi: 10.1161/ATVBAHA.109.197822
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Rodriguez, A. I.
Right arrow Articles by Bauer, P. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodriguez, A. I.
Right arrow Articles by Bauer, P. M.

Submitted on September 22, 2009
Accepted on October 15, 2009

HO-1 and CO Decrease Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cell Migration Via Inhibition of Nox1

Andres I. Rodriguez ; Archana Gangopadhyay ; Eric E. Kelley ; Patrick J. Pagano ; Brian S. Zuckerbraun ; and Philip M. Bauer *

From Department of Surgery (A.I.R., A.G., B.S.Z., P.M.B.), Department of Anesthesiology (E.E.K.), Department of Pharmacology and Chemical Biology (P.J.P., P.M.B.), and Vascular Medicine Institute (E.E.K., P.J.P., B.S.Z., P.M.B.), University of Pittsburgh School of Medicine, Pittsburgh, Pa.

* To whom correspondence should be addressed. E-mail: bauerpm{at}upmc.edu.

Objective—Heme oxygenase-1 (HO-1), via its enzymatic degradation products, exhibits cell and tissue protective effects in models of vascular injury and disease. The migration of vascular smooth muscle cells (VSMC) from the medial to the intimal layer of blood vessels plays an integral role in the development of a neointima in these models. Despite this, there are no studies addressing the effect of increased HO-1 expression on VSMC migration.

Results and Methods—The effects of increased HO-1 expression, as well as biliverdin, bilirubin, and carbon monoxide (CO), were studied in in vitro models of VSMC migration. Induction of HO-1 or CO, but not biliverdin or bilirubin, inhibited VSMC migration. This effect was mediated by the inhibition of Nox1 as determined by a range of approaches, including detection of intracellular superoxide, nicotinamide adenine dinucleotide phosphate oxidase activity measurements, and siRNA experiments. Furthermore, CO decreased platelet-derived growth factor-stimulated, redox-sensitive signaling pathways.

Conclusion—Herein, we demonstrate that increased HO-1 expression and CO decreases platelet-derived growth factor-stimulated VSMC migration via inhibition of Nox1 enzymatic activity. These studies reveal a novel mechanism by which HO-1 and CO may mediate their beneficial effects in arterial inflammation and injury.


Key words: carbon monoxide • heme oxygenase-1 • NADPH oxidase • Nox1 • vascular smooth muscle